Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Cancer02:18

Cancer

51.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.6K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

12.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Pigmentation01:19

Pigmentation

3.8K
The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
3.8K
Skin Cancer01:30

Skin Cancer

5.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Past, Present and Future: The Role of Sentinel Lymph Node Biopsy (SLNB) for Merkel Cell Carcinoma.

ANZ journal of surgery·2026
Same author

Standard neoadjuvant immunotherapy in patients with resectable stage III Melanoma - The early Australian experience.

European journal of cancer (Oxford, England : 1990)·2026
Same author

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment - update 2026.

European journal of cancer (Oxford, England : 1990)·2026
Same author

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention - Update 2026.

European journal of cancer (Oxford, England : 1990)·2026
Same author

On the survival benefit from sentinel node biopsy for melanoma.

The Lancet. Oncology·2026
Same author

Optimal Follow-Up of Sentinel Node Positive Melanoma Patients?

Annals of surgical oncology·2026
Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026
Same journal

Documenting hospice care.

Lancet (London, England)·2026
Same journal

After the wood chipper.

Lancet (London, England)·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Apr 29, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

13.9K

El melanoma

Dirk Schadendorf1, Alexander C J van Akkooi2, Carola Berking3

  • 1Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Heidelberg, Germany.

Lancet (London, England)
|September 22, 2018
PubMed
Resumen
Este resumen es generado por máquina.

El tratamiento avanzado del melanoma ha mejorado significativamente debido a las terapias dirigidas y la inmunoterapia. Estas innovaciones ofrecen nuevas esperanzas para el control a largo plazo y curas potenciales para el melanoma cutáneo avanzado.

Más Videos Relacionados

A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.2K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.9K

Videos de Experimentos Relacionados

Last Updated: Apr 29, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

13.9K
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.2K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.9K

Área de la Ciencia:

  • En el campo de la oncología
  • Dermatología
  • Investigación del cáncer

Sus antecedentes:

  • El melanoma cutáneo es un problema de salud mundial significativo, que causa muertes anuales sustanciales.
  • Las opciones de tratamiento para el melanoma avanzado fueron limitadas durante décadas, con ensayos clínicos históricamente fallidos.
  • Los recientes avances en el conocimiento biológico y terapéutico han revolucionado el tratamiento avanzado del melanoma.

Objetivo del estudio:

  • Revisar el progreso transformador en el tratamiento del melanoma cutáneo avanzado.
  • Destacar el impacto de los nuevos agentes y estrategias terapéuticas.

Principales métodos:

  • Revisión de los ensayos clínicos recientes y la investigación biológica en el melanoma avanzado.
  • Análisis de las terapias dirigidas, incluidos los inhibidores de BRAF y los inhibidores de MEK.
  • Evaluación de las inmunoterapias, específicamente los agentes moduladores del punto de control, como los anticuerpos anti-PD-1.

Principales resultados:

  • Las terapias dirigidas (inhibidores de BRAF/ MEK) han mejorado significativamente las tasas de respuesta y la supervivencia general en pacientes con mutaciones de BRAF V600.
  • Los inhibidores del punto de control (anti-PD-1) han mostrado éxito clínico en la enfermedad locorregional, prolongando la supervivencia total y sin recaídas.
  • El melanoma avanzado sirve como modelo para desarrollar nuevos tratamientos para los cánceres sólidos.

Conclusiones:

  • Los tratamientos innovadores han transformado el melanoma avanzado en una condición manejable con mejores resultados para los pacientes.
  • Los agentes dirigidos y la inmunoterapia ofrecen esperanza para la contención del tumor a largo plazo y posibles curas.
  • La investigación continua en el melanoma avanzado contribuye a avances oncológicos más amplios.